Active 0 6 0 6 O
duty 7 11 7 11 O
male 12 16 12 16 B-gender
or 17 19 17 19 I-gender
female 20 26 20 26 I-gender
, 26 27 26 27 O
of 28 30 28 30 O
any 31 34 31 34 O
race 35 39 35 39 O

Active 0 6 40 46 O
ophthalmic 7 17 47 57 B-chronic_disease
disease 18 25 58 65 I-chronic_disease
, 25 26 65 66 O
neovascularization 27 45 67 85 B-chronic_disease
of 46 48 86 88 I-chronic_disease
the 49 52 89 92 I-chronic_disease
cornea 53 59 93 99 I-chronic_disease
within 60 66 100 106 O
1 67 68 107 108 B-upper_bound
mm 69 71 109 111 I-upper_bound
of 72 74 112 114 O
the 75 78 115 118 O
intended 79 87 119 127 O
ablation 88 96 128 136 O
zone 97 101 137 141 O
, 101 102 141 142 O
or 103 105 143 145 O
lens 106 110 146 150 O
opacity 111 118 151 158 O

Any 0 3 159 162 O
physical 4 12 163 171 B-chronic_disease
or 13 15 172 174 I-chronic_disease
mental 16 22 175 181 I-chronic_disease
impairment 23 33 182 192 I-chronic_disease
which 34 39 193 198 O
would 40 45 199 204 O
preclude 46 54 205 213 O
participation 55 68 214 227 O
in 69 71 228 230 O
any 72 75 231 234 O
of 76 78 235 237 O
the 79 82 238 241 O
examinations 83 95 242 254 O
, 95 96 254 255 O
such 97 101 256 260 O
as 102 104 261 263 O
inability 105 114 264 273 O
to 115 117 274 276 O
give 118 122 277 281 O
verbal 123 129 282 288 O
responses 130 139 289 298 O
to 140 142 299 301 O
eye 143 146 302 305 O
charts 147 153 306 312 O

Best 0 4 313 317 O
spectacle 5 14 318 327 B-clinical_variable
corrected 15 24 328 337 I-clinical_variable
visual 25 31 338 344 I-clinical_variable
acuity 32 38 345 351 I-clinical_variable
of 39 41 352 354 O
20/25 42 47 355 360 B-upper_bound
or 48 50 361 363 O
better 51 57 364 370 O
in 58 60 371 373 O
both 61 65 374 378 O
eyes 66 70 379 383 O

Concurrent 0 10 384 394 B-treatment
topical 11 18 395 402 I-treatment
or 19 21 403 405 O
systemic 22 30 406 414 B-treatment
medications 31 42 415 426 I-treatment
which 43 48 427 432 O
may 49 52 433 436 O
impair 53 59 437 443 O
healing 60 67 444 451 O
, 67 68 451 452 O
including 69 78 453 462 O
corticosteroids 79 94 463 478 B-treatment
, 94 95 478 479 O
antimetabolites 96 111 480 495 B-treatment
, 111 112 495 496 O
isotretinoin 113 125 497 509 B-treatment
, 125 126 509 510 O
( 127 128 511 512 B-treatment
Accutane 128 136 512 520 I-treatment
™ 136 137 520 521 I-treatment
) 137 138 521 522 I-treatment
, 138 139 522 523 O
amiodarone 140 150 524 534 B-treatment
hydrochloride 151 164 535 548 I-treatment
( 165 166 549 550 I-treatment
Cordarone 166 175 550 559 I-treatment
™ 175 176 559 560 I-treatment
) 176 177 560 561 I-treatment
, 177 178 561 562 O
and/or 179 185 563 569 O
sumatriptan 186 197 570 581 B-treatment
( 198 199 582 583 I-treatment
Imitrex 199 206 583 590 I-treatment
™ 206 207 590 591 I-treatment
) 207 208 591 592 I-treatment

Evidence 0 8 593 601 O
of 9 11 602 604 O
glaucoma 12 20 605 613 B-chronic_disease
or 21 23 614 616 O
an 24 26 617 619 O
intraocular 27 38 620 631 B-clinical_variable
pressure 39 47 632 640 I-clinical_variable
greater 48 55 641 648 O
than 56 60 649 653 O
22 61 63 654 656 B-lower_bound
mm 64 66 657 659 I-lower_bound
Hg 67 69 660 662 I-lower_bound
at 70 72 663 665 I-lower_bound
baseline 73 81 666 674 I-lower_bound

Evidence 0 8 675 683 O
of 9 11 684 686 O
keratoconus 12 23 687 698 B-chronic_disease
, 23 24 698 699 O
corneal 25 32 700 707 B-chronic_disease
irregularity 33 45 708 720 I-chronic_disease
, 45 46 720 721 O
or 47 49 722 724 O
abnormal 50 58 725 733 O
videokeratography 59 76 734 751 B-treatment
in 77 79 752 754 O
either 80 86 755 761 O
eye 87 90 762 765 O

Female 0 6 766 772 B-gender
subjects 7 15 773 781 I-gender
who 16 19 782 785 O
are 20 23 786 789 B-pregnancy
pregnant 24 32 790 798 I-pregnancy
, 32 33 798 799 O
breast 34 40 800 806 O
- 40 41 806 807 O
feeding 41 48 807 814 O
, 48 49 814 815 O
or 50 52 816 818 O
intend 53 59 819 825 B-pregnancy
to 60 62 826 828 I-pregnancy
become 63 69 829 835 I-pregnancy
pregnant 70 78 836 844 I-pregnancy
during 79 85 845 851 O
the 86 89 852 855 O
course 90 96 856 862 O
of 97 99 863 865 O
the 100 103 866 869 O
study 104 109 870 875 O

Hard 0 4 876 880 O
contact 5 12 881 888 O
lens 13 17 889 893 O
users 18 23 894 899 O
( 24 25 900 901 O
PMMA 25 29 901 905 O
or 30 32 906 908 O
rigid 33 38 909 914 O
gas 39 42 915 918 O
permeable 43 52 919 928 O
lenses 53 59 929 935 O
) 59 60 935 936 O
must 61 65 937 941 O
have 66 70 942 946 O
removed 71 78 947 954 O
their 79 84 955 960 O
lenses 85 91 961 967 O
at 92 94 968 970 O
least 95 100 971 976 O
four 101 105 977 981 B-lower_bound
( 106 107 982 983 I-lower_bound
4 107 108 983 984 I-lower_bound
) 108 109 984 985 I-lower_bound
weeks 110 115 986 991 I-lower_bound
prior 116 121 992 997 I-lower_bound
to 122 124 998 1000 O
baseline 125 133 1001 1009 O
measurements 134 146 1010 1022 O

Manifest 0 8 1023 1031 B-clinical_variable
spherical 9 18 1032 1041 I-clinical_variable
equivalent 19 29 1042 1052 I-clinical_variable
( 30 31 1053 1054 I-clinical_variable
MSE 31 34 1054 1057 I-clinical_variable
) 34 35 1057 1058 I-clinical_variable
from 36 40 1059 1063 O
+3.00 41 46 1064 1069 B-lower_bound
D 47 48 1070 1071 I-lower_bound
to 49 51 1072 1074 O
-11.0D 52 58 1075 1081 B-upper_bound
with 59 63 1082 1086 O
refractive 64 74 1087 1097 B-clinical_variable
cylinder 75 83 1098 1106 I-clinical_variable
of 84 86 1107 1109 O
up 87 89 1110 1112 O
to 90 92 1113 1115 O
3.00 93 97 1116 1120 O
D 98 99 1121 1122 O

Medical 0 7 1123 1130 O
conditions 8 18 1131 1141 O
which 19 24 1142 1147 O
, 24 25 1147 1148 O
in 26 28 1149 1151 O
the 29 32 1152 1155 O
judgment 33 41 1156 1164 O
of 42 44 1165 1167 O
the 45 48 1168 1171 O
investigator 49 61 1172 1184 O
, 61 62 1184 1185 O
may 63 66 1186 1189 O
impair 67 73 1190 1196 O
healing 74 81 1197 1204 O
, 81 82 1204 1205 O
including 83 92 1206 1215 O
but 93 96 1216 1219 O
not 97 100 1220 1223 O
limited 101 108 1224 1231 O
to 109 111 1232 1234 O
thyroid 112 119 1235 1242 B-chronic_disease
disorders 120 129 1243 1252 I-chronic_disease
and 130 133 1253 1256 O
diabetes 134 142 1257 1265 B-chronic_disease

Patients 0 8 1266 1274 O
with 9 13 1275 1279 O
known 14 19 1280 1285 O
sensitivity 20 31 1286 1297 O
or 32 34 1298 1300 O
inappropriate 35 48 1301 1314 O
responsiveness 49 63 1315 1329 O
to 64 66 1330 1332 O
any 67 70 1333 1336 O
of 71 73 1337 1339 O
the 74 77 1340 1343 O
medications 78 89 1344 1355 B-allergy_name
used 90 94 1356 1360 I-allergy_name
in 95 97 1361 1363 I-allergy_name
the 98 101 1364 1367 I-allergy_name
post 102 106 1368 1372 I-allergy_name
- 106 107 1372 1373 I-allergy_name
operative 107 116 1373 1382 I-allergy_name
course 117 123 1383 1389 I-allergy_name

Soft 0 4 1390 1394 O
contact 5 12 1395 1402 O
lenses 13 19 1403 1409 O
must 20 24 1410 1414 O
have 25 29 1415 1419 O
been 30 34 1420 1424 O
removed 35 42 1425 1432 O
at 43 45 1433 1435 O
least 46 51 1436 1441 O
two 52 55 1442 1445 B-lower_bound
( 56 57 1446 1447 I-lower_bound
2 57 58 1447 1448 I-lower_bound
) 58 59 1448 1449 I-lower_bound
weeks 60 65 1450 1455 I-lower_bound
prior 66 71 1456 1461 I-lower_bound
to 72 74 1462 1464 O
baseline 75 83 1465 1473 O
measurements 84 96 1474 1486 O

Stable 0 6 1487 1493 O
spectacle 7 16 1494 1503 O
refraction 17 27 1504 1514 O
, 27 28 1514 1515 O
confirmed 29 38 1516 1525 O
by 39 41 1526 1528 O
clinical 42 50 1529 1537 O
records 51 58 1538 1545 O
. 58 59 1545 1546 O
Neither 60 67 1547 1554 O
the 68 71 1555 1558 O
spherical 72 81 1559 1568 O
nor 82 85 1569 1572 O
the 86 89 1573 1576 O
cylindrical 90 101 1577 1588 O
portion 102 109 1589 1596 O
of 110 112 1597 1599 O
the 113 116 1600 1603 O
refraction 117 127 1604 1614 O
may 128 131 1615 1618 O
have 132 136 1619 1623 O
changed 137 144 1624 1631 O
more 145 149 1632 1636 O
than 150 154 1637 1641 O
0.50 155 159 1642 1646 B-lower_bound
D 160 161 1647 1648 I-lower_bound
during 162 168 1649 1655 O
the 169 172 1656 1659 O
six 173 176 1660 1663 B-upper_bound
- 176 177 1663 1664 I-upper_bound
month 177 182 1664 1669 I-upper_bound
period 183 189 1670 1676 O
immediately 190 201 1677 1688 O
preceding 202 211 1689 1698 O
the 212 215 1699 1702 O
baseline 216 224 1703 1711 O
examination 225 236 1712 1723 O
for 237 240 1724 1727 O
myopic 241 247 1728 1734 O
patients 248 256 1735 1743 O
and 257 260 1744 1747 O
0.75 261 265 1748 1752 B-lower_bound
for 266 269 1753 1756 O
hyperopic 270 279 1757 1766 O
patients 280 288 1767 1775 O

Strong 0 6 1776 1782 O
motivation 7 17 1783 1793 O
for 18 21 1794 1797 O
attending 22 31 1798 1807 O
the 32 35 1808 1811 O
follow 36 42 1812 1818 O
- 42 43 1818 1819 O
up 43 45 1819 1821 O
visits 46 52 1822 1828 O
and 53 56 1829 1832 O
orders 57 63 1833 1839 O
to 64 66 1840 1842 O
remain 67 73 1843 1849 O
in 74 76 1850 1852 O
the 77 80 1853 1856 O
area 81 85 1857 1861 O
for 86 89 1862 1865 O
the 90 93 1866 1869 O
duration 94 102 1870 1878 O
of 103 105 1879 1881 O
at 106 108 1882 1884 O
least 109 114 1885 1890 O
twelve 115 121 1891 1897 B-lower_bound
months 122 128 1898 1904 I-lower_bound
of 129 131 1905 1907 O
follow 132 138 1908 1914 O
up 139 141 1915 1917 O

at 0 2 1918 1920 O
least 3 8 1921 1926 O
21 9 11 1927 1929 B-lower_bound
years 12 17 1930 1935 I-lower_bound
old 18 21 1936 1939 O
at 22 24 1940 1942 O
the 25 28 1943 1946 O
time 29 33 1947 1951 O
of 34 36 1952 1954 O
the 37 40 1955 1958 O
pre 41 44 1959 1962 O
- 44 45 1962 1963 O
operative 45 54 1963 1972 O
examination 55 66 1973 1984 O

